WE ARE COMMITED TO

Dr. Stefano De Renzis, Principal Investigator, European Molecular Biology Laboratory, Heidelberg, Germany, joined us on June 7, 2021, as the latest speaker in IBAB’s Research Seminar Series. Speaking about ‘Shaping Cells and Tissues: from Embryonic Development to Synthetic Morphogenesis’, Dr. Stefano discussed the principles of synthetic morphogenesis, that is the engineering of gene circuits and signal systems to re-construct and direct morphogenesis. His team elegantly uses optogenetics to understand morphogenetic events in the fruit fly Drosophila melagonaster; indeed, it was an engaging hour of science

Prof. Gayatri Saberwal has published a Commentary in Current Science titled ‘The many uses of data in public clinical trial registries’. In Prof. Saberwal’s words: “One of the primary uses of public clinical trial registries has been to let the public know about ongoing trials. Nevertheless, scholars have conducted a very wide variety of studies using registry data, that relate to ethics, health, science, innovation, regulatory issues, globalization, transparency and so on. It is important to recognize these many uses, since hopefully it should lead to a greater recognition of the importance of data in trial records being accurate and complete. It should also lead to greater funding for such research and the facilitation of such work in other ways.”

Prof. Bibha Choudhary and research scholar Shivangi Sharma, in collaboration with the laboratory of Prof. Sathees Raghavan of Indian Institute of Science, Bengaluru, have published a research article in Scientific Reports. Titled “Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats”, the study revealed that the oral administration of Disarib, a BCL2 inhibitor which has anti-tumour effects in various mouse tumour models, does not invoke significant side effects in rats.